Pill form of semaglutide fails to slow Alzheimer’s in large trial
A pill version of semaglutide, the ingredient in Ozempic and Wegovy, did not slow the progress of Alzheimer’s disease, drugmaker Novo Nordisk announced on Nov. 24.
Gut health, GLP-1 and AI – the issues shaping ingredients and NPD – Yahoo
Gut health, GLP-1 and AI – the issues shaping ingredients and NPD Yahoo
Quitting a GLP-1 Before Pregnancy Linked to Higher Weight Gain, Complications
By Ernie Mundell HealthDay ReporterTUESDAY, Nov. 25, 2025 (HealthDay News) — Women who stop taking a GLP-1 weight loss/diabetes medication just…
GLP-1 Weight-Loss Drug in Pill Form Shows Promise in Trial
By Ernie Mundell HealthDay ReporterTUESDAY, Nov. 25, 2025 (HealthDay News) — New clinical trial results bode well for what could be the first GLP-1…
PrecisionLife and Ovation Partner to Develop Precision Medicine Test to Inform Reimbursement of GLP-1 Anti-Obesity Drugs
Collaboration to support value-based reimbursement models for GLP-1 receptor agonists, optimizing patient outcomes, increasing markets, and healthcare sustainability. OXFORD, England and PORTLAND, ME, Nov. 25, 2025 /PRNewswire/ — Ovation.io, a leading human omics and clinical data…
Two Alzheimer’s Trial Failures Reveal Clinical Challenges
Two major clinical disappointments Johnson & Johnson’s anti-tau antibody and Novo Nordisk’s GLP-1 metabolic therapy underscore just how complex and Alzheimer’s remains.
Gut health, GLP-1 and AI – the issues shaping ingredients and NPD
At the Next Generation Ingredients 2025 conference, speakers from across the industry explored how health innovation and ethical sourcing are shaping consumer expectations. The post Gut health, GLP-1 and AI – the issues shaping ingredients and NPD appeared first on Just Food.
Akston Initiates Clinical Trial of Once-Weekly GLP-1 Weight-Management Therapy for Cats
Cornell University-led study evaluates novel protein therapy designed to help cats achieve a healthier body condition with convenient once-a-week dosing BEVERLY, Mass., Nov. 25, 2025 /PRNewswire/ — Akston, the Biotech Built for Pets, announced today the start of a clinical study at…
What’s for Dinner, Mom?
Illustrations by Lucas Burtin Sometimes I think I became a mother not in a hospital room but in a Trader Joe’s in New York City. It was May 2020. A masked but smizing employee took one look at my stomach and handed me a packet of dark-chocolate peanut-butter cups. “Happy Mother’s Day!” she said. I […]
STAT+: Pharmalittle: We’re reading about a Novo next-gen diabetes drug, a Novartis gene therapy, and more
Hello there and happy Tuesday from STAT’s London outpost, with Andrew Joseph here filling in for Mr. Pharmalot for the day. While it feels like things are slowing down stateside ahead of the Thanksgiving holiday, this place is busy diving full speed into Christmas already. We just hope you can enjoy whatever you’re celebrating whenever […]